Paul Sommer

Company: Decibel Therapeutics Inc.

Job title: Global Head Of Patient Experience & Innovation

Seminars:

Exploring how to Adapt the Engagement Strategies in Communities Resistance to Gene Therapies 11:00 am

Explore the unique challenge of addressing resistance within the Deaf and Hard of Hearing (DHH) community towards gene therapy and the concept of a “cure.” Discuss the delicate balance of advancing gene therapy initiatives while respecting the wishes of those who resist Emphasize the importance of diversity in advisory boards, including everyday individuals, parents, Deaf…Read more

day: Day 1